Safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with type 2 diabetes mellitus fasting during Ramadan: a systematic review and meta-analysis

doi:10.5662/wjm.v15.i4.105478

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2460)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

HTML

2102

Figures (1-3)

111

Tables (1-2)

122

Sum=2394

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=49

Dec 20, 2025 (publication date) through Aug 28, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Methodol. Dec 20, 2025; 15(4): 105478
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.105478

Open in New Tab Full Size Figure Download Figure

Figure 1 Flowchart on study retrieval and inclusion in the meta-analysis. GLP-1RA: Glucagon-like peptide-1 receptor agonist.

Open in New Tab Full Size Figure Download Figure

Figure 2 Forest plot demonstrating the mean difference. A: Glycated hemoglobin; B: Body weight in the glucagon-like peptide-1 receptor agonist (GLP-1RA) group vs the non-GLP-1RA group. GLP-1RA: Glucagon-like peptide-1 receptor agonist; MD: Mean difference.

Open in New Tab Full Size Figure Download Figure

Figure 3 Forest plot demonstrating the mean difference. A: Systolic blood pressure (BP); B: Diastolic BP; C: Total cholesterol; D: Triglyceride in the glucagon-like peptide-1 receptor agonist (GLP-1RA) group vs the non-GLP-1RA group. GLP-1RA: Glucagon-like peptide-1 receptor agonist; MD: Mean difference.

Citation: Kamrul-Hasan ABM, Pappachan JM, Ashraf H, Nagendra L, Dutta D, Kuchay MS, Shaikh S. Safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with type 2 diabetes mellitus fasting during Ramadan: a systematic review and meta-analysis. World J Methodol 2025; 15(4): 105478
URL: https://www.wjgnet.com/2222-0682/full/v15/i4/105478.htm
DOI: https://dx.doi.org/10.5662/wjm.v15.i4.105478